FCSK
L-fucose kinase
Also known as: FCSK_HUMAN, FLJ39408, FUK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N0W3
- Gene
- FCSK
- Ensembl
- ENSG00000157353
- Chromosome
- 16
- Canonical length
- 1084 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene belongs to the GHMP (galacto-, homoserine, mevalonate and phosphomevalonate) kinase family and catalyzes the phosphorylation of L-fucose to form beta-L-fucose 1-phosphate. This enzyme catalyzes the first step in the utilization of free L-fucose in glycoprotein and glycolipid synthesis. L-fucose may be important in mediating a number of cell-cell interactions such as blood group antigen recognition, inflammation, and metastatis. While several transcript variants may exist for this gene, the full-length nature of only one has been described to date. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1084 residues, UniProt reviewed canonical sequence.
>Q8N0W3|FCSK
1 MEQPKGVDWT VIILTCQYKD SVQVFQRELE VRQKREQIPA GTLLLAVEDP EKRVGSGGAT
61 LNALLVAAEH LSARAGFTVV TSDVLHSAWI LILHMGRDFP FDDCGRAFTC LPVENPEAPV
121 EALVCNLDCL LDIMTYRLGP GSPPGVWVCS TDMLLSVPAN PGISWDSFRG ARVIALPGSP
181 AYAQNHGVYL TDPQGLVLDI YYQGTEAEIQ RCVRPDGRVP LVSGVVFFSV ETAERLLATH
241 VSPPLDACTY LGLDSGARPV QLSLFFDILH CMAENVTRED FLVGRPPELG QGDADVAGYL
301 QSARAQLWRE LRDQPLTMAY VSSGSYSYMT SSASEFLLSL TLPGAPGAQI VHSQVEEQQL
361 LAAGSSVVSC LLEGPVQLGP GSVLQHCHLQ GPIHIGAGCL VTGLDTAHSK ALHGRELRDL
421 VLQGHHTRLH GSPGHAFTLV GRLDSWERQG AGTYLNVPWS EFFKRTGVRA WDLWDPETLP
481 AEYCLPSARL FPVLHPSREL GPQDLLWMLD HQEDGGEALR AWRASWRLSW EQLQPCLDRA
541 ATLASRRDLF FRQALHKARH VLEARQDLSL RPLIWAAVRE GCPGPLLATL DQVAAGAGDP
601 GVAARALACV ADVLGCMAEG RGGLRSGPAA NPEWMRPFSY LECGDLAAGV EALAQERDKW
661 LSRPALLVRA ARHYEGAGQI LIRQAVMSAQ HFVSTEQVEL PGPGQWVVAE CPARVDFSGG
721 WSDTPPLAYE LGGAVLGLAV RVDGRRPIGA RARRIPEPEL WLAVGPRQDE MTVKIVCRCL
781 ADLRDYCQPH APGALLKAAF ICAGIVHVHS ELQLSEQLLR TFGGGFELHT WSELPHGSGL
841 GTSSILAGTA LAALQRAAGR VVGTEALIHA VLHLEQVLTT GGGWQDQVGG LMPGIKVGRS
901 RAQLPLKVEV EEVTVPEGFV QKLNDHLLLV YTGKTRLARN LLQDVLRSWY ARLPAVVQNA
961 HSLVRQTEEC AEGFRQGSLP LLGQCLTSYW EQKKLMAPGC EPLTVRRMMD VLAPHVHGQS
1021 LAGAGGGGFL YLLTKEPQQK EALEAVLAKT EGLGNYSIHL VEVDTQGLSL KLLGTEASTC
1081 CPFPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FCSK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- kidney: 10 nTPM
- duodenum: 9.6 nTPM
- pituitary gland: 9.6 nTPM
- parathyroid gland: 8.5 nTPM
- pancreas: 8.1 nTPM
- cerebellum: 7.9 nTPM
Single-cell type
- early primary spermatocytes: 39 nCPM
- myonuclei: 32 nCPM
- cone photoreceptor cells: 29 nCPM
- enterocytes: 26 nCPM
- colonocytes: 21 nCPM
- proximal tubule cells: 20 nCPM
Immune cell
- naive CD4 T-cell: 2.6 nTPM
- gdT-cell: 2 nTPM
- classical monocyte: 1.9 nTPM
- memory CD4 T-cell: 1.9 nTPM
- memory CD8 T-cell: 1.9 nTPM
- MAIT T-cell: 1.6 nTPM
Brain region
- white matter: 37 nTPM
- choroid plexus: 33 nTPM
- cerebellum: 33 nTPM
- cerebral cortex: 33 nTPM
- basal ganglia: 30 nTPM
- medulla oblongata: 30 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FCSK.
Disease | AllUniProt
Conditions FCSK is implicated in, by any mechanism.
- Congenital disorder of glycosylation with defective fucosylation 2 (CDGF2) MIM:618324
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 688 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital disorder of glycosylation with defective fucosylation 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- fucokinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FCSK as an antibody target. Whether an autoantibody or antibody against FCSK could matter depends on whether native FCSK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FCSK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FCSK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...